Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brincidofovir for CMV Prevention in HCT Recipients
NCT00942305Phase 2Completed
- Sponsor
- Chimerix Inc.
- Start
- Oct 2009
- Primary completion
- Jan 2012
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of brincidofovir in cytomegalovirus infection (CMV), sponsored by Chimerix Inc.. Started Oct 2009; status: completed.
02
Drugs
brincidofovir
03
Conditions
cytomegalovirus infection (CMV)
Beyond the preview
Go deeper on NCT00942305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00942305.